Advanced
Products
Solutions
Partners
Resources
Company
Toggle menu
Home
/
TransGenex Nanobiotech
TransGenex Nanobiotech
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
TransGenex Nanobiotech
TransGenex Nanobiotech Summary
Company summary
Overview
TransGenex Nanobiotech (TGN) is a company that develops cancer stem cell-based diagnostic technologies. It offers drug development, discovery, and delivery, 3D tumor cell biology, genomic testing, and other services.
Type
Private
Status
Active
Founded
2004
HQ
Tampa, FL, US
|
view all locations
Website
https://www.transgenex.com
Cybersecurity rating
Sectors
Technology
drug development
drug monitoring
medical diagnostics
Homepage
Linkedin
facebook
youtube
twitter
Key people
Mazen Hanna,
President and Board of Director
Linkedin
Bernard Skerkowski,
VP of Finance
Chandresh Saraiya,
VP of Medical Affairs
Sagar Galwankar,
VP of Marketing and Global Operations
Locations
View all
2 locations detected
Tampa, FL
HQ
United States
13713 N Nebraska Ave
Tampa, FL
United States
3802 Spectrum Blvd #141
Report incorrect company information
Competitors and similar companies
Nanospectra Biosciences
Healthcare - Private
Nanovalent Pharmaceuticals
Healthcare - Private
Nanovery
Healthcare - Private
DevaCell
Healthcare - Private
Compare competitors
Footer menu
Contact us
Facebook
Twitter
LinkedIn
Products
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Press
Company
About
Careers
Terms of Service
Privacy Policy
© Craft.co 2023
Share price data provided by IEX
Company directory
Search directory
Back
to top